Search results
Found 2370 matches for
The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a high level of protection.
NEW - Home
Welcome to Oxford Vaccine Group
Known Issues
The content listed below is non-accessible for the following reasons:
Study with us
We are committed to providing high quality education and training, together with research updates for medical professionals and all those involved in the area of vaccines and paediatric and adult infectious diseases.